Vanda Pharmaceuticals Files 8-K
Ticker: VNDA · Form: 8-K · Filed: Oct 15, 2024 · CIK: 1347178
| Field | Detail |
|---|---|
| Company | Vanda Pharmaceuticals Inc. (VNDA) |
| Form Type | 8-K |
| Filed Date | Oct 15, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, disclosure, regulatory
Related Tickers: VNDA
TL;DR
Vanda Pharma filed an 8-K on Oct 15th for events on Oct 14th.
AI Summary
Vanda Pharmaceuticals Inc. filed an 8-K on October 15, 2024, reporting other events and financial statements. The filing pertains to events that occurred on October 14, 2024. The company is incorporated in Delaware and its principal executive offices are located in Washington, D.C.
Why It Matters
This 8-K filing indicates that Vanda Pharmaceuticals Inc. is providing updates or disclosures to the SEC, which could contain material information for investors.
Risk Assessment
Risk Level: low — This filing is a routine disclosure and does not appear to contain immediate, significant negative or positive news.
Key Players & Entities
- Vanda Pharmaceuticals Inc. (company) — Registrant
- October 15, 2024 (date) — Date of Report
- October 14, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 2200 Pennsylvania Avenue NW Suite 300E Washington, DC 20037 (address) — Principal executive offices
- (202) 734-3400 (phone_number) — Registrant's telephone number
FAQ
What specific 'Other Events' are being reported by Vanda Pharmaceuticals Inc. in this 8-K?
The filing indicates 'Other Events' as an item information, but the specific details of these events are not provided in the excerpt.
What is the significance of the 'Financial Statements and Exhibits' being filed?
This suggests that the company is providing updated financial information or exhibits as required by the SEC, though the content of these is not detailed in the excerpt.
When was Vanda Pharmaceuticals Inc. incorporated, and where are its principal executive offices located?
Vanda Pharmaceuticals Inc. is incorporated in Delaware and its principal executive offices are located at 2200 Pennsylvania Avenue NW, Suite 300E, Washington, DC 20037.
What is the SEC file number and IRS Employer Identification Number for Vanda Pharmaceuticals Inc.?
The SEC file number is 001-34186 and the IRS Employer Identification Number is 03-0491827.
What is the SIC code for Vanda Pharmaceuticals Inc.?
The Standard Industrial Classification (SIC) code for Vanda Pharmaceuticals Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 508 words · 2 min read · ~2 pages · Grade level 10.7 · Accepted 2024-10-15 08:00:01
Key Financial Figures
- $0.001 — ich registered Common Stock, par value $0.001 per share VNDA The Nasdaq Global Ma
Filing Documents
- d840698d8k.htm (8-K) — 26KB
- d840698dex991.htm (EX-99.1) — 8KB
- g840698g1014234818389.jpg (GRAPHIC) — 4KB
- 0001193125-24-237220.txt ( ) — 199KB
- vnda-20241014.xsd (EX-101.SCH) — 4KB
- vnda-20241014_def.xml (EX-101.DEF) — 13KB
- vnda-20241014_lab.xml (EX-101.LAB) — 22KB
- vnda-20241014_pre.xml (EX-101.PRE) — 14KB
- d840698d8k_htm.xml (XML) — 6KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press release of Vanda Pharmaceuticals Inc. dated October 14, 2024. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: October 15, 2024 VANDA PHARMACEUTICALS INC. By: /s/ Timothy Williams Name: Timothy Williams Title: Senior Vice President, General Counsel and Secretary